Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
Close filters
Filter by:
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
from to

Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

Filter
12255 from 12274 pages
No results were found for the filter!
Carbonic anhydrase inhibitor 5
Carbonic anhydrase inhibitor 5

Item number: TGM-T62976-100mg

TargetMol
Description: Carbonic anhydrase inhibitor 5 is a potent and selective inhibitor of human carbonic anhydrase (hCA), targeting hCA II (IC50: 42.9 nM), hCA IX (IC50: 47.6 nM), and hCA XII (IC50: 6.7 nM). Target: Others
MW: 465.95 D
From 1,440.00€ *
Show details
Review
HIV-IN-3
HIV-IN-3

Item number: TGM-T62978-100mg

TargetMol
Description: HIV-IN-3 (Compound 22a) is a potent HIV inhibitor (IC50: 1.5 µM) with potential for studying HIV-related diseases. Target: Others
MW: 465.98 D
From 1,440.00€ *
Show details
Review
iNOs-IN-1
iNOs-IN-1

Item number: TGM-T62987-100mg

TargetMol
Description: iNOs-IN-1 (YPW) is a potent inhibitor of inducible nitric oxide synthase (iNOS) with anti-inflammatory effects, significantly inhibiting IL-6 and iNOS expression in a dose-dependent manner in murine macrophages, and also inhibiting LPS-induced NO generation. Target: Others
MW: 466.53 D
From 867.00€ *
Show details
Review
IRAK4-IN-12
IRAK4-IN-12

Item number: TGM-T62989-100mg

TargetMol
Description: IRAK4-IN-12 (compound 37) is a potent inhibitor of IRAK4 with an IC50 of 0.015 µM and demonstrates cellular pIRAK4 potency with an IC50 of 0.5 µM. Target: Others
MW: 466.55 D
From 1,440.00€ *
Show details
Review
PI3K/AKT-IN-1
PI3K/AKT-IN-1

Item number: TGM-T62997-100mg

TargetMol
Description: PI3K/AKT-IN-1 is a potent, dual PI3K/AKT inhibitor that acts on PI3Kgamma (IC50: 6.99 µM), PI3Kdelta (IC50: 4.01 µM) and AKT (IC50: 3.36 µM). PI3K/AKT-IN-1 induces caspase 3-dependent apoptosis by inhibiting the PI3K/AKT pathway. caspase 3-dependent apoptosis and exhibited anticancer effects. Target:...
MW: 467.54 D
From 393.00€ *
Show details
Review
VEGFR-2-IN-15
VEGFR-2-IN-15

Item number: TGM-T63002-100mg

TargetMol
Description: VEGFR-2-IN-15 (Compound 14b) is a potent VEGFR-2 inhibitor that inhibits the growth of HepG2 cells in the Pre-G1 phase and induces apoptosis. Target: Others
MW: 467.92 D
From 1,440.00€ *
Show details
Review
DHU-Se1
DHU-Se1

Item number: TGM-T63006-100mg

TargetMol
Description: DHU-Se1 is a potent anti-inflammatory agent that stimulates the release of reactive selenium compounds from macrophages and reduces the expression of cellular inflammatory factors such as iNOS and TNF-alpha. Additionally, DHU-Se1 blocks the polarization of macrophages from M0 to M1, thereby alleviating...
MW: 468.47 D
From 1,440.00€ *
Show details
Review
SphK2-IN-2
SphK2-IN-2

Item number: TGM-T63017-100mg

TargetMol
Description: SphK2-IN-2 (21g) is a potent and selective SphK2 inhibitor with an IC50 of 0.23 µM. Target: Others
MW: 468.94 D
From 1,440.00€ *
Show details
Review
GKA50 quarterhydrate
GKA50 quarterhydrate

Item number: TGM-T63019-100mg

TargetMol
Description: GKA50 quarterhydrate is a potent glucokinase activator with an EC50 value of 33 nM. This glucose-like activator of beta-cell metabolism in rodent and human pancreatic islets is a Ca2+-dependent regulator of insulin secretion. It stimulates insulin secretion in mouse islets and significantly reduces...
MW: 469.01 D
From 1,251.00€ *
Show details
Review
PTP1B-IN-17
PTP1B-IN-17

Item number: TGM-T63021-100mg

TargetMol
Description: PTP1B-IN-17 (Compound 45) is a selective benzimidazole derivative with potential as a protein tyrosine phosphatase 1B (PTP1B) inhibitor (Ki: 30.2 µM). PTP1B-IN-17 can be used in the study of type 2 diabetes. Target: Others
MW: 469.51 D
From 1,440.00€ *
Show details
Review
PTP1B-IN-18
PTP1B-IN-18

Item number: TGM-T63022-100mg

TargetMol
Description: PTP1B-IN-18 is an orally active, fully mixed protein tyrosine phosphatase 1B (PTP1B) inhibitor with a Ki of 35.2 µM, and it can be used for the study of type 2 diabetes. Target: Others
MW: 469.51 D
From 1,440.00€ *
Show details
Review
PTP1B-IN-19
PTP1B-IN-19

Item number: TGM-T63023-100mg

TargetMol
Description: PTP1B-IN-19 (Compound 43) is a promising selective benzimidazole derivative that acts as a protein tyrosine phosphatase 1B (PTP1B) inhibitor with a Ki of 23.3 µM. This compound, along with PTP1B-IN-17, can be utilized in the study of type 2 diabetes. Target: Others
MW: 469.51 D
From 1,440.00€ *
Show details
Review
12255 from 12274 pages
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent. More information
Decline Accept all Configure